Fig. 3From: Combined markers for predicting cognitive deficit in patients with Alzheimer’s diseaseCytokinesis-block micronucleus assay (CBMN); showing binucleated micronucleated (BNMN) lymphocyte of an AD patient, arrow pointed to the micronucleusBack to article page